Every one of those 1 sits in a single category, product-launch. Of the tracked stories, 1 of 1 also mention Captivate, the most common co-covered peer. The 7 average consequence score is above the beat benchmark of 6.6 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about AI-Powered Clinical Trial Build Platform
Every one of those 1 sits in a single category, product-launch. Of the tracked stories, 1 of 1 also mention Captivate, the most common co-covered peer. The 7 average consequence score is above the beat benchmark of 6.6 in the same window. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. AI-Powered Clinical Trial Build Platform appears in 1 tracked Startup story from March 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 52 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering AI-Powered Clinical Trial Build Platform. Shared-story counts are live from our verified record — not editorial picks.
ClinCapture CEO Scott Weidley has launched an AI-powered study build engine within the Captivate platform, designed to automate the translation of clinical protocols into digital trial environments. By embedding AI into the core architecture rather than as an external layer, the company aims to eliminate manual configuration errors and significantly accelerate the timeline from protocol to patient.
AI-Powered Clinical Trial Build Platform is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.